State Street’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-20,905
Closed -$51K 4963
2022
Q2
$51K Sell
20,905
-188
-0.9% -$894 ﹤0.01% 4719
2022
Q1
$146K Buy
21,093
+7,747
+58% +$82.1K ﹤0.01% 4507
2021
Q4
$212K Buy
13,346
+246
+2% +$4.92K ﹤0.01% 4324
2021
Q3
$263K Buy
+13,100
New +$338K ﹤0.01% 4255

Other funds holding RNLX

State Street's RNLX Position: Q3 2022 in Review

State Street sold out of Renalytix plc American Depositary Shares (RNLX) in Q3 2022, closing a stake of 20,905 shares — an estimated $51K sold.

State Street first reported a position in RNLX in Q3 2021 and held it in 4 quarters. The position peaked at $263K in Q3 2021. 27 funds tracked by Wall St. Rank hold RNLX as of Q3 2022.

  • State Street reported no remaining Renalytix plc American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • State Street sold 20,905 Renalytix plc American Depositary Shares shares in Q3 2022, an estimated $51K.
  • State Street first reported a position in Renalytix plc American Depositary Shares in Q3 2021 and held it in 4 quarters.
  • State Street's Renalytix plc American Depositary Shares position peaked at $263K in Q3 2021.
  • 27 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q3 2022.

Based on State Street's 13F filing for Q3 2022, filed 15 Nov 2022.